The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer

Published:2024-03 Issue: Volume:192 Page:110091
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Saylor Philip J.,Kozin Sergey V.,Matsui Aya,Goldberg Saveli I.,Aoki Shuichi,Shigeta Kohei,Mamessier Emilie,Smith Matthew R.,Michaelson M. Dror,Lee Richard J.,Duda Dan G.

Funder

National Institutes of Health

U.S. Department of Defense

Bayer Corporation

Bayer Fund

Publisher

Elsevier BV

Reference34 articles.

1. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013

2. Radionuclide therapy for osseous metastases in prostate cancer;Abi-Ghanem;Semin Nucl Med,2015

3. An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223;Sartor;Ann Oncol,2017

4. Radium-223 in the treatment of osteoblastic metastases: a critical clinical review;Humm;Int J Radiat Oncol Biol Phys,2015

5. Whole-Body and Microenvironmental Localization of Radium-223 in Naive and Mouse Models of Prostate Cancer Metastasis;Abou;J Natl Cancer Inst,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP